down arrow

Biogen Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.94
0.02 (2.17%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2022 is 52.48% vs 0.00% in Mar 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2022 is 99.05% vs -1,273.79% in Mar 2021

stock-summary

Interest

YoY Growth in year ended Mar 2022 is 327.35% vs 0.00% in Mar 2021

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2022 is 99.46% vs -1,273.83% in Mar 2021

Compare Profit and Loss Results of Biogen Pharma
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2.00
644.00
-642.00
-99.69%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2.00
644.00
-642.00
-99.69%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
2.00
571.00
-569.00
-99.65%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
5.00
-5.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
0.00
-1.00
1.00
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
46.00
-46.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2.00
631.00
-629.00
-99.68%
Operating Profit (PBDIT) excl Other Income
0.00
12.00
-12.00
-100.00%
Other Income
0.00
23.00
-23.00
-100.00%
Operating Profit (PBDIT)
0.00
36.00
-36.00
-100.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
35.00
-35.00
-100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
35.00
-35.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
35.00
-35.00
-100.00%
Provision for Tax
0.00
10.00
-10.00
-100.00%
Profit After Tax
0.00
25.00
-25.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-11.00
320.00
-331.00
-103.44%
Profit Available for appropriations
-11.00
345.00
-356.00
-103.19%
Appropriations
-11.00
345.00
-356.00
-103.19%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.0001
2.91
-2.91
-100.00%
Profit And Loss - Net Sales
Net Sales 2.47 Cr
in Mar 2022

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2022 is 52.48% vs 0.00% in Mar 2021

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.02 Cr
in Mar 2022

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2022 is 99.05% vs -1,273.79% in Mar 2021

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2022

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2022 is 327.35% vs 0.00% in Mar 2021

Profit And Loss - Profit After Tax
Profit After Tax -0.01 Cr
in Mar 2022

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2022 is 99.46% vs -1,273.83% in Mar 2021